A full-proteome, interaction-specific characterization of mutational hotspots across human cancers

  1. Haiyuan Yu1,2
  1. 1Department of Computational Biology, Cornell University, Ithaca, New York 14853, USA;
  2. 2Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York 14853, USA;
  3. 3Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York 14853, USA;
  4. 4Department of Medicine, Weill Cornell Medicine, New York, New York 10021, USA
  • 5 Present address: Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA

  • Corresponding author: haiyuan.yu{at}cornell.edu
  • Abstract

    Rapid accumulation of cancer genomic data has led to the identification of an increasing number of mutational hotspots with uncharacterized significance. Here we present a biologically informed computational framework that characterizes the functional relevance of all 1107 published mutational hotspots identified in approximately 25,000 tumor samples across 41 cancer types in the context of a human 3D interactome network, in which the interface of each interaction is mapped at residue resolution. Hotspots reside in network hub proteins and are enriched on protein interaction interfaces, suggesting that alteration of specific protein–protein interactions is critical for the oncogenicity of many hotspot mutations. Our framework enables, for the first time, systematic identification of specific protein interactions affected by hotspot mutations at the full proteome scale. Furthermore, by constructing a hotspot-affected network that connects all hotspot-affected interactions throughout the whole-human interactome, we uncover genome-wide relationships among hotspots and implicate novel cancer proteins that do not harbor hotspot mutations themselves. Moreover, applying our network-based framework to specific cancer types identifies clinically significant hotspots that can be used for prognosis and therapy targets. Overall, we show that our framework bridges the gap between the statistical significance of mutational hotspots and their biological and clinical significance in human cancers.

    Footnotes

    • Received February 24, 2021.
    • Accepted November 22, 2021.

    This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see https://genome.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

    This article has not yet been cited by other articles.

    This Article

    1. Genome Res. © 2022 Chen et al.; Published by Cold Spring Harbor Laboratory Press

    Article Category

    ORCID

    Share

    Preprint Server